Home › Acute Lymphoblastic Leukemia › New York › Greenburgh
Acute Lymphoblastic Leukemia clinical trials in Greenburgh, NY
4 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in and around Greenburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- New York Medical College, Valhalla · 5 mi away
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
RecruitingPhase 2
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi away
A Study of Revumenib and Mezigdomide in People With Leukemia
RecruitingPhase 1/2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi away
A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
RecruitingPhase 1
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi away
Acute Lymphoblastic Leukemia trials in other cities
- Houston, TX28 studies
- New York City, NY24 studies
- Baldwin Park, CA21 studies
- Seattle, WA21 studies
- Atlanta, GA19 studies
- Chicago, IL19 studies
- Memphis, TN16 studies
- Philadelphia, PA16 studies
- Washington, DC16 studies
- Boston, MA15 studies
- Los Angeles, CA14 studies
- Durham, NC13 studies
Other studies in Greenburgh
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer28 studies
- Acute Myeloid Leukemia18 studies
- Prostate Cancer17 studies
- Cancer (all types)17 studies
- Lung Cancer17 studies
- Multiple Myeloma13 studies
- Colorectal Cancer11 studies
- Metastatic Cancer11 studies
- Endometrial Cancer11 studies
- Bladder Cancer10 studies
- Head and Neck Squamous Cell Carcinoma9 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.